Evaluate The Pipeline Of Key Products With Canada Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5f3503/canada_drug_delive) has announced the addition of the "Canada Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012" report to their offering.

Canada Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Canada drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Canada

Scope

- The report provides drug delivery devices information broken down into detailed categories and segments in Canada.

- Total revenues, products sold, end users, and average pricing.

- Market shares of all the key competitors.

- Key pipeline products that are set to shape the market, broken down by sector.

- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.

- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.

- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

- Key mergers and acquisitions, partnerships, private equity investments and IPOs.

- Customer, hospitals and physicians data.

Key Topics Covered:

1 Contents

2 Introduction

3 Healthcare Sector Review

4 Drug Delivery Devices in Canada

5 Inhalation Systems in Canada

6 Infusion Systems in Canada

7 Needle Free Injections in Canada

8 AstraZeneca PLC Company Profile

9 GlaxoSmithKline plc Company Profile

10 3M Company Profile

11 Baxter International Company Profile

12 Hospira, Inc. Company Profile

13 Regulation System

14 Pricing and Reimbursement

15 Distribution Structure

16 Recent Developments

17 Appendix

Executive Summary

1.1 List of Tables

Companies Mentioned:

AstraZeneca PLC

GlaxoSmithKline plc

3M Company

Baxter International

Hospira, Inc.

For more information visit http://www.researchandmarkets.com/research/5f3503/canada_drug_delive

Source: Global Markets Direct